Giovanni Rossi

3.5k total citations
114 papers, 2.3k citations indexed

About

Giovanni Rossi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Giovanni Rossi has authored 114 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 51 papers in Oncology and 20 papers in Molecular Biology. Recurrent topics in Giovanni Rossi's work include Lung Cancer Treatments and Mutations (27 papers), Cancer Immunotherapy and Biomarkers (26 papers) and Lung Cancer Research Studies (14 papers). Giovanni Rossi is often cited by papers focused on Lung Cancer Treatments and Mutations (27 papers), Cancer Immunotherapy and Biomarkers (26 papers) and Lung Cancer Research Studies (14 papers). Giovanni Rossi collaborates with scholars based in Italy, United States and France. Giovanni Rossi's co-authors include Carlo Genova, Ronald G. Crystal, Francesco Grossi, Simona Coco, Pasquale Strazzullo, R. Ippolito, Francesco P. Cappuccio, Lanfranco D’Elia, Victor J. Ferrans and Erika Rijavec and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Cancer Research.

In The Last Decade

Giovanni Rossi

110 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giovanni Rossi Italy 26 1.0k 790 442 329 303 114 2.3k
Antonio Ghidini Italy 27 695 0.7× 1.4k 1.8× 435 1.0× 319 1.0× 362 1.2× 91 2.3k
William W. West United States 23 804 0.8× 679 0.9× 370 0.8× 217 0.7× 222 0.7× 58 2.1k
G. Ferretti Italy 30 512 0.5× 1.2k 1.5× 690 1.6× 258 0.8× 579 1.9× 150 2.7k
Haibo Qiu China 23 936 0.9× 907 1.1× 532 1.2× 540 1.6× 455 1.5× 141 2.6k
Theodoros Karantanos United States 25 831 0.8× 758 1.0× 1.0k 2.3× 300 0.9× 450 1.5× 78 2.7k
Yan Yan China 30 1.1k 1.0× 544 0.7× 831 1.9× 543 1.7× 442 1.5× 164 2.7k
Nobumichi Tanaka Japan 29 1.3k 1.3× 649 0.8× 656 1.5× 899 2.7× 314 1.0× 248 3.0k
Timothy Craig Allen United States 26 1.1k 1.1× 434 0.5× 669 1.5× 244 0.7× 369 1.2× 90 2.5k
Kalyan Saginala United States 12 1.0k 1.0× 880 1.1× 1.0k 2.3× 638 1.9× 424 1.4× 13 2.9k
David J. Tate Australia 29 1.3k 1.2× 1.0k 1.3× 559 1.3× 656 2.0× 111 0.4× 121 3.0k

Countries citing papers authored by Giovanni Rossi

Since Specialization
Citations

This map shows the geographic impact of Giovanni Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Rossi more than expected).

Fields of papers citing papers by Giovanni Rossi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanni Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Rossi. The network helps show where Giovanni Rossi may publish in the future.

Co-authorship network of co-authors of Giovanni Rossi

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanni Rossi. A scholar is included among the top collaborators of Giovanni Rossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanni Rossi. Giovanni Rossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Zullo, Lodovica, Filippo Gustavo Dall’Olio, Giovanni Rossi, et al.. (2023). Molecular and Genetic Advances in Small Cell Lung Cancer Landscape: From Homogeneity to Diversity. International Journal of Molecular Sciences. 25(1). 224–224. 3 indexed citations
4.
Rossi, Giovanni, Alessandro Fedeli, Lodovica Zullo, et al.. (2022). Exploring Response to Immunotherapy in Non-Small Cell Lung Cancer Using Delta-Radiomics. Cancers. 14(2). 350–350. 34 indexed citations
5.
Zullo, Lodovica, Giovanni Rossi, Simona Coco, et al.. (2022). Immunotherapy-chemotherapy combinations for non-small cell lung cancer: current trends and future perspectives. Expert Opinion on Biological Therapy. 22(10). 1259–1273. 17 indexed citations
6.
Mencoboni, Manlio, Vincenzo Fontana, Alessandro Raso, et al.. (2022). Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy. Current Oncology. 29(5). 3364–3374. 4 indexed citations
7.
Carrega, Paolo, Lodovica Zullo, Chiara Dellepiane, et al.. (2022). Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy. Cancers. 14(20). 5046–5046. 14 indexed citations
8.
Rebuzzi, Sara Elena, Lodovica Zullo, Giovanni Rossi, et al.. (2021). Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 22(5). 2625–2625. 40 indexed citations
9.
Bauckneht, Matteo, Carlo Genova, Giovanni Rossi, et al.. (2021). The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab. Cancers. 13(13). 3117–3117. 20 indexed citations
10.
Carbone, Federico, Stefano Ministrini, Aldo Bonaventura, et al.. (2021). Serum levels of VCAM‐1 are associated with survival in patients treated with nivolumab for NSCLC. European Journal of Clinical Investigation. 52(1). e13668–e13668. 7 indexed citations
11.
Rossi, Giovanni, Lodovica Zullo, Luigi Cerbone, et al.. (2020). ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentarium. Expert Opinion on Pharmacotherapy. 21(6). 679–686. 2 indexed citations
12.
Rossi, Giovanni, Alessandro Russo, Marco Tagliamento, et al.. (2020). Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient. Cancers. 12(5). 1125–1125. 48 indexed citations
13.
Rossi, Giovanni, Alessandro Fedeli, Gianluca Ficarra, et al.. (2020). Radiomic Detection of EGFR Mutations in NSCLC. Cancer Research. 81(3). 724–731. 78 indexed citations
14.
Genova, Carlo, Giovanni Rossi, Marco Tagliamento, et al.. (2020). Targeted therapy of oncogenic-driven advanced non-small cell lung cancer: recent advances and new perspectives. Expert Review of Respiratory Medicine. 14(4). 367–383. 21 indexed citations
15.
Alama, Angela, Simona Coco, Carlo Genova, et al.. (2019). Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab. Journal of Clinical Medicine. 8(7). 1011–1011. 45 indexed citations
16.
Bonaventura, Aldo, Francesco Grossi, Federico Carbone, et al.. (2019). Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study. Cancer Immunology Immunotherapy. 68(8). 1351–1358. 28 indexed citations
17.
Tagliamento, Marco, Carlo Genova, Giovanni Rossi, et al.. (2019). Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds. Expert Opinion on Investigational Drugs. 28(6). 513–523. 22 indexed citations
18.
Genova, Carlo, Simona Boccardo, Marco Mora, et al.. (2019). Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab. Journal of Clinical Medicine. 8(10). 1566–1566. 23 indexed citations
19.
Tagliamento, Marco, Francesco Grossi, Sabrina Paolino, et al.. (2019). Nivolumab Treatment in Advanced Lung Cancer Patient With Chronic Active Hepatitis C and Systemic Lupus Erythematosus. Immunotherapy. 11(10). 873–879. 11 indexed citations
20.
Rossi, Giovanni, Angela Alama, Carlo Genova, et al.. (2018). The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer. Expert Opinion on Pharmacotherapy. 19(17). 1969–1976. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Ghidini Breakdown of academic impact, for papers by William W. West Breakdown of academic impact, for papers by G. Ferretti Breakdown of academic impact, for papers by Haibo Qiu Breakdown of academic impact, for papers by Theodoros Karantanos Breakdown of academic impact, for papers by Yan Yan Breakdown of academic impact, for papers by Nobumichi Tanaka Breakdown of academic impact, for papers by Timothy Craig Allen Breakdown of academic impact, for papers by Kalyan Saginala Breakdown of academic impact, for papers by David J. Tate
Rankless by CCL
2026